Justin Schreiber

Why Novo Nordisk’s GLP-1 Pill Breakthrough is Shaking Up Eli Lilly’s Market Dominance: A Must-Read for Investors

When Novo Nordisk launched the Wegovy pill in January, telehealth provider LifeMD saw its business nearly double overnight. CEO Justin ... Read more